Creative Healthcare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 23 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1.05%
- Profit Growth -100.15%
- Ebitda -19.55%
- Net Worth -0.01%
- Total Assets 18.20%
About Creative Healthcare Pharmaceuticals
Creative Healthcare Pharmaceuticals Private Limited (CHPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 August 2001 and has a history of 23 years and five months. Its registered office is in Bareilly, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Saraswat and Ghanshyam Saraswat serve as directors at the Company.
Company Details
-
Location
Bareilly, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232UP2001PTC026194
-
Company No.
026194
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Aug 2001
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Creative Healthcare Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Saraswat
|
Director | 24-Aug-2001 | Current |
|
Ghanshyam Saraswat
|
Director | 24-Aug-2001 | Current |
Financial Performance of Creative Healthcare Pharmaceuticals.
Creative Healthcare Pharmaceuticals Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 1.05% increase. The company also saw a substantial fall in profitability, with a 100.15% decrease in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Creative Healthcare Pharmaceuticals?
In 2017, Creative Healthcare Pharmaceuticals had a promoter holding of 40.00% and a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Creative Healthcare Pharmaceuticals?
Unlock and access historical data on people associated with Creative Healthcare Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Creative Healthcare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Creative Healthcare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
